Jump to main content
References: Opioids: hazardous, harmful and dependent use
Australian Institute of Health and Welfare (AIHW). Opioid harm in Australia: and comparisons between Australia and Canada. Canberra: Australian Government, AIHW. 2018; Updated November 2021. Accessed October 2022. https://www.aihw.gov.au/reports/illicit-use-of-drugs/opioid-harm-in-australia/summary Centre for Alcohol and Other Drugs. Clinical Guidelines for the Management of Substance Use During Pregnancy, Birth and the Postnatal Period. Sydney: NSW Ministry of Health 2014. https://www.health.nsw.gov.au/aod/resources/Publications/substance-use-pregnant-parenting.pdf Centre for Alcohol and Other Drugs. NSW clinical guidelines: treatment of opioid dependence 2018. Sydney: NSW Health; 2018. Accessed Sept 2022. https://www.health.nsw.gov.au/aod/Pages/nsw-clinical-guidelines-opioid.aspx Faggiano F, Vigna-Taglianti F, Versino E, Lemma P. Methadone maintenance at different dosages for opioid dependence. Cochrane Database Syst Rev 2003;(3):CD002208. https://www.ncbi.nlm.nih.gov/pubmed/12917925 Gowing L, Ali R, Dunlop A, Farrell M, Lintzeris N. National Guidelines for Medication-Assisted Treatment of Opioid Dependence. 2014. https://www.health.gov.au/resources/publications/national-guidelines-for-medication-assisted-treatment-of-opioid-dependence Gowing L, Ali R, White JM, Mbewe D. Buprenorphine for managing opioid withdrawal. Cochrane Database Syst Rev 2017;2:CD002025. https://www.ncbi.nlm.nih.gov/pubmed/28220474 Manning V, Arunogiri S, Frei M, Ridley K, Mroz K, Campbell S, et al. Alcohol and other Drug Withdrawal: Practice Guidelines. 3rd ed. Richmond, Victoria: Turning Point; 2018. https://www.turningpoint.org.au/treatment/clinicians/aod-withdrawal-guidelines Mattick RP, Breen C, Kimber J, Davoli M. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database Syst Rev 2014;(2):CD002207. https://www.ncbi.nlm.nih.gov/pubmed/24500948 Mattick RP, Breen C, Kimber J, Davoli M. Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database Syst Rev 2009;(3):CD002209. https://www.ncbi.nlm.nih.gov/pubmed/19588333 McNeely J, Halkitis PN, Horton A, Khan R, Gourevitch MN. How patients understand the term "nonmedical use" of prescription drugs: insights from cognitive interviews. Subst Abus 2014;35(1):12-20. https://www.ncbi.nlm.nih.gov/pubmed/24588288 NSW Health. Drug and Alcohol Withdrawal Clinical Practice Guidelines - NSW. 2008. https://www1.health.nsw.gov.au/pds/ActivePDSDocuments/GL2008_011.pdf NSW Health. Management of Withdrawal from Alcohol and Other Drugs_Clinical Guidance. St Leonards, NSW: NSW Ministry of Health; 2022. https://www.health.nsw.gov.au/aod/professionals/Pages/clinical-guidance.aspx Picco L, Middleton M, Bruno R, Kowalski M, Nielsen S. Validation of the OWLS, a Screening Tool for Measuring Prescription Opioid Use Disorder in Primary Care. Pain Med 2020;21(11):2757-64. https://www.ncbi.nlm.nih.gov/pubmed/32869062 Queensland Health. Queensland medication-assisted treatment of opioid dependence: clinical guidelines (2018). Brisbane: State of Queensland (Queensland Health); 2018. https://www.health.qld.gov.au/clinical-practice/guidelines-procedures/clinical-staff/mental-health/guidelines RADAR. Buprenorphine with naloxone (Suboxone Sublingual Film) for opiate dependence. RADAR. Sydney: NPSMedicineWise; 2011. https://www.nps.org.au/radar/articles/buprenorphine-with-naloxone-suboxone-sublingual-film-for-opiate-dependence SA Health. Benzodiazepine withdrawal management. SA Health; Updated April 2022. Accessed September 2022. https://www.sahealth.sa.gov.au/wps/wcm/connect/Public+Content/SA+Health+Internet/Clinical+Resources/Clinical+Programs+and+Practice+Guidelines/Substance+misuse+and+dependence/Substance+withdrawal+management/Benzodiazepine+Withdrawal+Management SA Health. Opioid withdrawal management. Adelaide: Government of South Australia. Updated April 2022. Accessed September 2022. https://www.sahealth.sa.gov.au/wps/wcm/connect/public+content/sa+health+internet/clinical+resources/clinical+programs+and+practice+guidelines/substance+misuse+and+dependence/substance+withdrawal+management/opioid+withdrawal+management Victoria Department of Health. Buprenorphine. Updated August 2022. Accessed October 2022. https://www.health.vic.gov.au/drugs-and-poisons/buprenorphine# Victoria Department of Health. Guide to prescribing buprenorphine/naloxone and long-acting injectable buprenorphine. Melbourne: Victorian Government; 2021. Accessed Oct 2022. https://www.health.vic.gov.au/publications/brief-guide-to-prescribing-buprenorphine
